Boston Scientific SVP reports RSU and option grants

Boston Scientific SVP Emily Woodworth reported multiple equity awards and an RSU exercise.

Accepted by SEC EDGAR 02/17/2026 - 07:07 PM EST

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Boston Scientific SVP Emily Woodworth reported multiple equity awards and an RSU exercise. On February 12, 2026, she exercised 481 restricted stock units into 481 common shares at an exercise price of $0.0000 and had 242 shares withheld at $74.12 per share to cover tax obligations, leaving 951 common shares directly owned. She also received 6,071 new restricted stock units and a grant of 5,584 stock options with a $74.12 exercise price, each vesting in four equal annual installments starting February 12, 2027.

Insider Trade Summary

481 shares exercised/converted

Exercise 5 txns

Insider Woodworth Emily

Role SVP, Global Controller and CAO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	481	$0.00	$0.00
Grant/Award	Restricted Stock Units	6,071	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	5,584	$0.00	$0.00
Exercise	Common Stock	481	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	242	$74.12	$18K

Holdings After Transaction: Restricted Stock Units — 7,033 contracts (Direct); Stock Option (Right to Buy) — 5,584 contracts (Direct); Common Stock — 951 shares (Direct)

Holdings Before and After: Restricted Stock Units, 1,443 to 7,033 contracts (Direct); Stock Option (Right to Buy), 0 to 5,584 contracts (Direct); Common Stock, 712 to 951 shares (Direct)

Footnotes (5)

F1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2. Includes shares acquired on June 30, 2025 under the Company's Employee Stock Purchase Plan based upon the most current data available.
F3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F4. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.
F5. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Boston Scientific SVP Emily Woodworth report in this Form 4 for BSX?

Emily Woodworth reported equity awards and an RSU exercise. She exercised 481 restricted stock units into common shares, had 242 shares withheld for taxes, and received 6,071 new RSUs plus 5,584 stock options, all held as direct ownership.

How many Boston Scientific (BSX) restricted stock units did Emily Woodworth acquire?

She acquired 6,071 new restricted stock units. Each unit represents a commitment to issue one Boston Scientific common share, with shares scheduled to be delivered in four equal annual installments beginning February 12, 2027, according to the footnote description in the filing.

What stock option grant did Emily Woodworth receive from Boston Scientific (BSX)?

She received a grant of 5,584 stock options with a $74.12 exercise price. These options vest in four equal annual installments beginning February 12, 2027, giving her the right to purchase Boston Scientific common shares at that price as they vest.

How many Boston Scientific (BSX) common shares does Emily Woodworth own after these transactions?

After the reported transactions, she directly owns 951 Boston Scientific common shares. This reflects 481 shares issued upon RSU exercise and 242 shares disposed of to satisfy tax obligations, as shown in the non-derivative holdings table of the Form 4.

What was the purpose of the 242 Boston Scientific (BSX) shares disposed of by code F?

The 242 common shares marked with transaction code F were withheld to cover tax liabilities. Code F in the Form 4 indicates payment of exercise price or tax obligations by delivering securities, rather than an open-market sale by the reporting person.

How many restricted stock units does Emily Woodworth hold in total after the BSX Form 4 transactions?

Following the reported transactions, she holds 962 restricted stock units from the exercised award and 6,071 new restricted stock units. These derivative holdings represent Boston Scientific’s commitment to deliver the same number of common shares over specified vesting schedules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Woodworth Emily

(Last)

(First)

(Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH

01752-1234

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Global Controller and CAO

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/12/2026		M		481	A	$0.0000⁽¹⁾	1,193⁽²⁾	D
Common Stock	02/12/2026		F		242	D	$74.12	951	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	02/12/2026		M			481	⁽³⁾	02/12/2028⁽³⁾	Common Stock	481	$0.0000	962	D
Restricted Stock Units	⁽¹⁾	02/12/2026		A		6,071		⁽⁴⁾	02/12/2030⁽⁴⁾	Common Stock	6,071	$0.0000	6,071	D
Stock Option (Right to Buy)	$74.12	02/12/2026		A		5,584		⁽⁵⁾	02/12/2036	Common Stock	5,584	$0.0000	5,584	D

Explanation of Responses:

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Includes shares acquired on June 30, 2025 under the Company's Employee Stock Purchase Plan based upon the most current data available.

3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.

4. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

5. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

	/s/ Susan Thompson, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR